United Therapeutics presents preliminary PHINDER study data to develop PH-ILD screening tool at CHEST 2026
Bitget2026/10/13 11:02- United Therapeutics disclosed it will present new clinical data at the CHEST 2026 meeting in Phoenix on Oct. 18-21, 2026.
- An oral update will report how inhaled treprostinil performed in the TETON-IPF program in slowing disease worsening in idiopathic pulmonary fibrosis.
- Separate PHINDER analyses will be presented on mortality risk scoring in interstitial lung disease, supporting development of earlier screening approaches for PH-ILD.
- The FDA accepted an NDA for ralinepag in pulmonary arterial hypertension, keeping a potential new commercial product under review.
- The agency also accepted a supplemental NDA for nebulized treprostinil in idiopathic pulmonary fibrosis, positioning it as a second regulatory catalyst.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Retail investors bet on AI infrastructure rebound, shares of South Korean cloud operator Elice rise above IPO price in two days
After plummeting 32% on its first trading day, South Korean cloud service provider Elice rebounded strongly for two consecutive days, surging as much as 25% and reclaiming its IPO price for the first time. Retail investors actively bottom-fished driven by the limit-up effect, while institutional investors questioned its financing resilience and execution capabilities. Whether the AI infrastructure sector is a value hotspot or a capital trap has become an intensifying point of contention in the market.
Japanese stocks closed down 2.65%
AI trading concerns reignite: global bond markets see renewed safe-haven buying, funds flow back into U.S. Treasuries
Weakness in the stock market has triggered safe-haven buying, driving gains in US Treasuries, the Japanese yen, and the Swiss franc. Yields on US Treasuries have declined across the board, with the 30-year yield reaching its lowest level since late September.
Unafraid of the electric vehicle downturn: General Motors (GM.US) makes a bold bet on lithium-manganese-based batteries, wagering on the next generation of affordable electric vehicles
General Motors (GM.US) remains undeterred by the electric vehicle market downturn in recent years and is moving forward with a brand new EV project, aiming to launch a new battery-powered mainstream SUV in approximately three years.
Crypto prices
More
